Early Supplemental Parenteral Nutrition in Critically Ill Children: An Update.
An JacobsInes VerlindenIlse VanhorebeekGreet Van den BerghePublished in: Journal of clinical medicine (2019)
In critically ill children admitted to pediatric intensive care units (PICUs), enteral nutrition (EN) is often delayed due to gastrointestinal dysfunction or interrupted. Since a macronutrient deficit in these patients has been associated with adverse outcomes in observational studies, supplemental parenteral nutrition (PN) in PICUs has long been widely advised to meeting nutritional requirements. However, uncertainty of timing of initiation, optimal dose and composition of PN has led to a wide variation in previous guidelines and current clinical practices. The PEPaNIC (Early versus Late Parenteral Nutrition in the Pediatric ICU) randomized controlled trial recently showed that withholding PN in the first week in PICUs reduced incidence of new infections and accelerated recovery as compared with providing supplemental PN early (within 24 hours after PICU admission), irrespective of diagnosis, severity of illness, risk of malnutrition or age. The early withholding of amino acids in particular, which are powerful suppressors of intracellular quality control by autophagy, statistically explained this outcome benefit. Importantly, two years after PICU admission, not providing supplemental PN early in PICUs did not negatively affect mortality, growth or health status, and significantly improved neurocognitive development. These findings have an important impact on the recently issued guidelines for PN administration to critically ill children. In this review, we summarize the most recent literature that provides evidence on the implications for clinical practice with regard to the use of early supplemental PN in critically ill children.
Keyphrases
- randomized controlled trial
- clinical practice
- young adults
- intensive care unit
- healthcare
- quality control
- primary care
- end stage renal disease
- chronic kidney disease
- cell death
- type diabetes
- newly diagnosed
- signaling pathway
- study protocol
- ejection fraction
- risk factors
- prognostic factors
- coronary artery disease
- patient reported outcomes